FindTrial
Sign In

The intelligent matching of red blood cell blood type genes in the application of precise blood transfusion

The intelligent matching of red blood cell blood type genes in the application of precise blood transfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122716
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia patients

Interventions

Control group:Administer the infusion of regular red blood cells
Experimental group:Administering red blood cell transfusion with genetically matched cells

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 18 - 75 years old; 2.Sign the informed consent form; 3.Meets the criteria for blood transfusion; 4.Patients with blood diseases who require long-term blood transfusions;

Exclusion criteria

Exclusion criteria: 1.Age less than 18 or greater than 75 years old; 2.There are contraindications for blood transfusion.

Design outcomes

Primary

MeasureTime frame
The incidence rate of transfusion reactions;—

Secondary

MeasureTime frame
The increase in HGB (HGB value after blood transfusion - HGB value before blood transfusion);The degree of decrease in TBIL;Length of hospital stay;—

Countries

China

Contacts

Public ContactCai Xiaohong

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

cxh8407@126.com+86 21 64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026